Eden Innovations (ASX: EDE) has appointed Dr Allan Godsk Larsen as managing director to spearhead global growth, a move supported by significant debt reduction and strong order momentum for its EdenCrete Pz7 and OptiBlend systems.
His focus will be on leading the company's next phase of global growth.
His compensation includes an annual cash salary of AUD 400,000 and 21 million performance rights.
These rights vest across three years, tied to Volume Weighted Average Price (VWAP) hurdles of AUD 0.15, AUD 0.19, and AUD 0.24.
This key appointment comes at a time of significant balance sheet strengthening and substantial debt reduction for the company.
Debt Reduction Continues
Eden Innovations has reduced its total debt by approximately AUD 16 million since June 30, 2025. This effort marks a strategic improvement to the company's financial position.
A key part of this reduction includes the elimination of high-interest debt and a AUD 2.2 million convertible note from 7 Enterprises.
These steps follow a recapitalisation effort that saw an AUD 4.35 million equity placement and the successful repayment of the iBorrow loan.
EdenCrete Pz7 Sales Momentum
Momentum for EdenCrete Pz7 continues to build, highlighted by Holcim Ecuador placing its largest order to date. This order is valued at approximately AUD 514,000.
Eden Innovations estimates annual sales to Holcim Ecuador alone could reach AUD 1.2 million.
The product is also gaining traction in US infrastructure projects and undergoing expanded government testing in India for potential use in highways and bridges.
OptiBlend Gains Traction
The company's OptiBlend dual-fuel systems are also seeing increased adoption. Orders for OptiBlend in the USA have secured approximately USD 487,000.
Furthermore, active quotations for OptiBlend in the USA currently stand at approximately USD 4.14 million.
These systems are proving popular, supported by robust US infrastructure demand.
Outlook for Accelerated Growth
The appointment of an experienced Managing Director, coupled with a significantly de-risked balance sheet and confirmed product momentum, positions Eden Innovations for accelerated global growth.
While execution risk remains, the company's strategic steps indicate a strong focus on capitalizing on its product pipeline and market opportunities.
